Findings may have important public health implications for chronic disease prevention.
Early markers of cardiovascular and metabolic disease were elevated in adolescents with psoriasis, despite early disease.
Based on EHR data, room for improvement found in BP control, health care processes such as meds intensification
Substituting margarine, butter, mayonnaise, and dairy fat with olive oil may lower risk.
Study findings suggest the benefits of continuing ACEi or ARB therapy outweigh the risks in CKD patients with an eGFR less than 30 mL/min/1.73 m2.
Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed.
Currently, there are no antivirals licensed by the FDA to treat patients with COVID-19.
A middle-aged woman with a 15-year history of hereditary transthyretin amyloidosis had a reduction in cardiac amyloid load.
The Centers for Disease Control and Prevention (CDC) released preliminary data related to outcomes among US patients with coronavirus disease 2019 (COVID-19).
Increased serum tenascin-C concentrations are associated with risk for death and major adverse cardiovascular events in individuals with type 2 diabetes.